CAN A CURE BE ACHIEVED WITH TAXANE-BASED CHEMOTHERAPY IN PATIENTS WITH PRIMARY MEDIASTINAL NON-SEMINOMATOUS GERM CELL TUMORS (NGCT) AND PROGRESSION OR RELAPSE DESPITE FIRST-LINE CHEMOTHERAPY?

被引：0
|
作者：
Miskovska, V. [1 ]
Levy, A. [1 ]
Sauvin, L. Albiges [1 ]
Massard, C. [1 ]
Gross-Goupil, M. [1 ]
Bossi, A. [1 ]
Fizazi, K. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 205
页数：2
相关论文
共 50 条
  • [31] SIMULTANEOUS VERSUS SEQUENTIAL RETROPERITONEAL AND THORACIC RESECTION OF POST CHEMOTHERAPY RESIDUAL MASSES IN PATIENTS WITH METASTATIC NON-SEMINOMATOUS GERM CELL TUMORS OF THE TESTIS
    Nason, Gregory
    Donahoe, Laura
    Aditya, Ishan
    De Perrot, Marc
    Anson-Cartwright, Lynn
    Jewett, Michael
    Hansen, Aaron
    Bedard, Philippe
    Warde, Padraig
    Chung, Peter
    Sweet, Joan
    O'Malley, Martin
    Hamilton, Robert
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1068 - E1068
  • [32] Post-chemotherapy retroperitoneal lymph node dissection can not be safely omitted in patients with metastatic non-seminomatous germ cell testis cancer
    Nguyen, Carvell T.
    Subramanian, Vairavan S.
    Stephenson, Andrew J.
    Klein, Eric A.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 176 - 176
  • [33] The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer
    Petersen, PM
    Hansen, SW
    ANNALS OF ONCOLOGY, 1999, 10 (12) : 1475 - 1483
  • [34] Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy
    Berruti, A
    Saini, A
    Gorzegno, G
    Tampellini, M
    Borasio, P
    Dogliotti, L
    ANNALS OF ONCOLOGY, 2003, 14 (10) : 1589 - 1590
  • [35] NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - ANALYSIS OF AFP AND HCG PRODUCTION BY PRIMARY TUMORS AND RETROPERITONEAL LYMPH-NODE METASTASES AFTER PVB COMBINATION CHEMOTHERAPY
    SUURMEIJER, AJH
    OOSTERHUIS, JW
    MARRINK, J
    DEBRUIN, HWA
    KOOPS, HS
    SLEIJFER, DT
    FLEUREN, GJ
    ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1983, 4 (04): : 289 - 308
  • [36] First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
    Bokemeyer, C
    Schleucher, N
    Metzner, B
    Thomas, M
    Rick, O
    Schmoll, HJ
    Kollmannsberger, C
    Boehlke, I
    Kanz, L
    Hartmann, JT
    BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 29 - 35
  • [37] First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
    C Bokemeyer
    N Schleucher
    B Metzner
    M Thomas
    O Rick
    H-J Schmoll
    C Kollmannsberger
    I Boehlke
    L Kanz
    J T Hartmann
    British Journal of Cancer, 2003, 89 : 29 - 35
  • [38] Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxane-based Chemotherapy for Stage IV Non-Small-cell Lung Cancer in a US Community Oncology Setting
    Weiss, Jared
    Force, Rex W.
    Pugmire, Brook A.
    Peterson, Teri
    Faria, Claudio
    Margunato-Debay, Sandra
    Patel, Manish B.
    CLINICAL LUNG CANCER, 2017, 18 (04) : 372 - 380
  • [39] Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
    Beyer, Joerg
    Lorch, Anja
    Beyer, Joerg
    Bascoul-Mollevi, C.
    Kramar, A.
    Einhorn, Lawrence H.
    Necchi, A.
    Massard, C.
    De Giorgi, U.
    Flechon, A.
    Margolin, Kim A.
    Lotz, Jean-Pierre
    Lluch, Jose Ramon Germa
    Powles, Thomas
    Kollmannsberger, Christian K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : 4906 - 4911
  • [40] High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis
    Beyer, J
    Stenning, S
    Gerl, A
    Fossa, S
    Siegert, W
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 599 - 605
12345